SCHEMBL1702560

SCHEMBL1702560

CC1(c2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 11/20 0.45
PARP4 Q9UKK3 2/20 0.45
PARP1 P09874 2/20 0.45
CA2 P00918 2/20 0.45
PARP2 Q9UGN5 2/20 0.45
CA1 P00915 1/20 0.45
TSHR P16473 2/20 0.44
PARP15 Q460N3 4/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
PARP14 Q460N5 1/20 0.43
PARP16 Q8N5Y8 1/20 0.43
PARP11 Q9NR21 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
PMP22 Q01453 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14744167 0.87 PARP1 (0.44) PARP10PARP4PARP1CA2PARP2
SCHEMBL29639813 0.84 CES1 (0.35) CA2CA1LMNA
SCHEMBL13351657 0.82 PARP10 (0.46) PARP10PARP4PARP1CA2PARP2
SCHEMBL18291832 0.81 MAPK1 (0.45) ALDH1A1KMT2AMAPTCYP2C19TDP1
SCHEMBL15956227 0.81 TP53 (0.52) CA2CA1TSHRALDH1A1CYP3A4
SCHEMBL22712558 0.79 LMNA (0.46) ALDH1A1CYP2C19BLMHSD17B10NOS1
SCHEMBL5297495 0.77 PARP10 (0.45) PARP10PARP4PARP1CA2PARP2
SCHEMBL12973676 0.76 HSD17B1 (0.53) KMT2AMAPTL3MBTL1LMNA
SCHEMBL15956007 0.76 CA1 (0.53) CA2CA1TSHRALDH1A1KMT2A
SCHEMBL9178767 0.75 PARP10 (0.50) PARP10PARP4PARP1CA2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440528-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-10-08 EP disclosed
CN-102803216-A Heterocyclic antiviral compounds HOFFMANN LA ROCHE 2012-11-28 CN disclosed
EP-2440528-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-04-18 EP disclosed
WO-2010142656-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-16 WO disclosed